How To Prescribe
Below are the steps you and your patient’s parents take to activate the treatment.

First, you prescribe the treatment.

Send prescription to Phil* pharmacy through either:
*Phil pharmacy specializes in digital treatment prescriptions, and
manages all prescriptions for EndeavorRx.


Include:
- Primary ICD-10 code
- Instructions for play1
- Number of refills1
1See Instructions for Use

Next, parents enroll, pay, and activate.
Parents can enroll online with a phone in a matter of minutes.

Phil pharmacy texts parents the enrollment link


Parents
enroll online


Parents pay and receive activation code


Parents download app and activate treatment

Parents should also pair treatment with our free companion app that tracks their child’s in-game progress.

Then, guide your patient to make progress.
Follow up
Follow up both during & after treatment to discuss progress and next steps. Empower parents by learning more about our tips for success.
TIPS & TRICKSRefills
EndeavorRx demonstrates incremental efficacy with two months of treatment, so prescribe with refills. Reach out to Phil for questions.

Cost & Coverage
To learn more contact
Phil pharmacy:
- 855-977-0975
- akiliassist@usephil.com
If insurance covers EndeavorRx, the out-of-pocket cost will vary based on insurance plan benefits.


Patient Assistance Program
If EndeavorRx is not covered by an insurance, learn more about our options for making your treatment affordable.
Discover the ProgramHave questions? Email Phil at akiliassist@usephil.com
We’re here to support you.

Talk with
a Rep
Schedule a meeting with one of our reps to learn more about how to prescribe EndeavorRx and request educational materials for your office.
Schedule Now
Download Our Media Kit
Use our pre-designed assets in your office, on your website, and on your social channels to let people know you’re prescribing EndeavorRx.
Download NowEndeavorRx:
Indications, Safety and Cautions
Indications:
EndeavorRx is a digital therapeutic indicated to improve attention function as measured by computer-based testing in children ages 8-12 years old with primarily inattentive or combined-type ADHD, who have a demonstrated attention issue. Patients who engage with EndeavorRx demonstrate improvements in a digitally assessed measure, Test of Variables of Attention (TOVA®), of sustained and selective attention and may not display benefits in typical behavioral symptoms, such as hyperactivity. EndeavorRx should be considered for use as part of a therapeutic program that may include clinician-directed therapy, medication, and/or educational programs, which further address symptoms of the disorder.
Safety:
No serious adverse events were reported. Of 538 participants in trials supporting EndeavorRx authorization, 50 participants (9.3%) experienced treatment-related adverse events (probable, likely), and three participants experienced treatment-related adverse events with the digital control, in studies where a control was used. Associated adverse events included frustration (6.1%), headache (1.3%), dizziness (0.6%), emotional reaction (0.4%), nausea (0.4%), and aggression (0.2%). All adverse events were generally transient. Only 3 events led to device discontinuation, and no subject reported lasting or irreversible effects after discontinuation.
Cautions:
Rx only: Federal law restricts this device to sale by or on the order of a licensed health care provider. EndeavorRx should only be used by the patient for whom the prescription was written. For medical questions, please contact your child’s healthcare provider. If you are experiencing a medical emergency, please dial 911. EndeavorRx is not intended to be used as a stand-alone therapeutic and is not a substitution for your child’s medication.
If your child experiences frustration, emotional reaction, dizziness, nausea, headache, eye-strain, or joint pain while playing EndeavorRx pause the treatment. If the problem persists contact your child’s healthcare provider. If your child experiences a seizure stop the treatment and contact your child’s healthcare provider.
EndeavorRx may not be appropriate for patients with photo-sensitive epilepsy, color blindness, or physical limitations that restrict use of a mobile device; parents should consult with their child’s healthcare provider.
Please follow all of your mobile device manufacturer’s instructions for the safe operation of your mobile device. For example, this may include appropriate volume settings, proper battery charging, not operating the device if damaged, and proper device disposal. Contact your mobile device manufacturer for any questions or concerns that pertain to your device.